Issue :

Saudi FDA issued Recall all batches of MOXICLAV 1 gm Film Coted Tablet due to the composition of outer coating of tablets in the marketed batches not matching the composition of batch used in the bioequivalence study that was submitted to the authority.

Recommendations :

For healthcare professionals, Stop dispensing the above product immediately. Embargo/Quarantine all remaining stock. Affected product should be returned to the supplier.

for patients

• Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
• Contact the recalling firm or Saudi FDA if you have any questions about the recall.
• Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).